Transforming lives with stem cell medicine
The Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW) is an international collaboration which will pave the way for future stem cell-based treatments.
Based in Melbourne, Leiden and Copenhagen, reNEW has been made possible through a record stem cell medicine grant of up to €300 million over 10 years from the Novo Nordisk Foundation.
The Melbourne node is based at the Murdoch Children's Research Institute.
Murdoch Children's Research Institute is a key part of this international consortium and builds on our expertise in the development of stem cell-based therapies and regenerative medicine.
MCRI expertise will advance stem cell research to therapies
- MCRI is embedded within the Royal Children’s Hospital with a focus on understanding and treating childhood diseases
- MCRI is internationally recognised for its research using human induced pluripotent stem cells to drive cell and gene-based therapies on the Melbourne Children's Campus
- MCRI houses state-of-the-art facilities required to advance stem cell medicine
- MCRI is part of the Parkville biomedical precinct, enabling MCRI to lead research and collaborate with experts, to deliver stem cell medical breakthroughs directly into the clinic
"reNEW presents an opportunity to continue to build on our stem cell expertise and capabilities at reNEW Melbourne and the Melbourne Children’s Campus, towards delivering innovative stem cell-based therapies and to transform the lives of children with incurable disease."
Professor Enzo Porrello, Node Director of reNEW Melbourne.
Proudly in partnership with
The Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW, is supported by a Novo Nordisk Foundation grant number NNF21CC0073729